JODID

This brand name is authorized in Austria, Germany, Poland, Romania, Turkey

Active ingredients

The drug JODID contains one active pharmaceutical ingredient (API):

1 Potassium iodide UNII 1C4QK22F9J - POTASSIUM IODIDE

Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities. Read about Potassium iodide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H03CA	Iodine therapy	H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03C Iodine therapy
Discover more medicines within H03CA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02545005, 03105998, 03106130, 03799133, 03942955, 03943676, 04619133, 04619156, 04620001, 04620018
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100032570, 100201617
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66151003, W66151004
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699808010117, 8699808010124